Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant and IP Chemotherapy in Stage III/IV Ovarian Cancer
NCT00008138Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 2001
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by SWOG Cancer Research Network. Started Mar 2001; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00008138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008138.